Evidence map›Paper›PMID 35937405›Full record

ArticleBioMed research international2022

Clinical Value of sTREM-1, PCT, and 1,3-

Lei Yan, Yuan Li, Chunye Wu, Yuquan Shi, Chunyu Kong

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Retracted: Clinical Value of sTREM-1, PCT, and 1,3-BioMed research international · 2024
    Article
4 · The record

Corrections and comments

  • Retraction · 2024-01-09Concerns/Issues about Data · Concerns/Issues about Results and/or Conclusions · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Computer-Aided Content or Computer-Generated Content · Unreliable Results and/or Conclusions ·
  • Retracted
5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lei YanDepartment of Rheumatology and Immunology, Tianjin First Central Hospital, Tianjin 300192, China.ORCID https://orcid.org/0000-0002-3619-8659
Yuan LiDepartment of Rheumatology and Immunology, Tianjin First Central Hospital, Tianjin 300192, China.
Chunye WuDepartment of Rheumatology and Immunology, Tianjin First Central Hospital, Tianjin 300192, China.
Yuquan ShiDepartment of Rheumatology and Immunology, Tianjin First Central Hospital, Tianjin 300192, China.
Chunyu KongDepartment of Rheumatology and Immunology, Tianjin First Central Hospital, Tianjin 300192, China.
Tianjin First Center Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fungal infection in the lungs can cause fungal infectious diseases. This disease develops rapidly and involves a wide range. Pathogenic fungi are also more serious types of pathogenic bacteria. If it invades deep organs and tissues, it will endanger life, so it needs timely diagnosis. Aim: To investigate the diagnostic value of serum soluble myeloid cell triggering receptor-1 (sTREM-1), procalcitonin (PCT), and 1,3- Methods: In this study, a case-control study was conducted. 50 patients with immune-related pulmonary disease complicated with fungal infection (infection group) diagnosed by sputum culture in our hospital from January 2017 to December 2021 were selected as the control group, and 50 patients with immune-related pulmonary disease without fungal infection were selected as the control group. The levels of sTREM-1, PCT, and 1,3- Results: The levels of sTREM-1, PCT, and 1,3- Conclusion: The detection of sTREM-1, PCT, and 1,3-

Indexed as

beta-GlucansImmune System DiseasesLung DiseasesMycosesBiomarkersCase-Control StudiesC-Reactive ProteinHumansLungMyeloid CellsProcalcitoninProspective StudiesTriggering Receptor Expressed on Myeloid Cells-1beta-GlucansBiomarkersC-Reactive ProteinProcalcitoninTriggering Receptor Expressed on Myeloid Cells-1

Identifiers

PMID35937405
PMCPMC9348935
OpenAlexW4288068238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.